The University of Maryland Medical Center is a teaching hospital with 757 beds based in Baltimore, Maryland, that provides the full range of health care to people throughout Maryland and the Mid-Atlantic region. It gets more than 35,000 inpatient admissions and 165,000 outpatient visits each year.

There are 767 beds in Ummc Msgcc.

During the past decade, Ummc Msgcc conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 6 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 5 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ummc Msgcc" #1 collaborator was "National Institutes of Health (NIH)" with 1 trials as a collaborator, "NovoCure Ltd." with 1 trials as a collaborator and "University of Maryland" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Ummc Msgcc" are "Breast Cancer" (2 trials), "Lung Cancer" (2 trials), "Brain Tumor" (1 trials), "Breast Cancer With Brain Metastasis" (1 trials) and "Cancer" (1 trials). Many other conditions were trialed in "Ummc Msgcc" in a lesser frequency.

Most popular intervention types in "Ummc Msgcc" are "Radiation" (4 trials), "Drug" (2 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Chemotherapy with Temodar." (1 trials), "Contrast-enhanced 4D computed tomography" (1 trials), "FOLFOX {5-fluorouracil (5-FU), leucovorin, and oxaliplatin}" (1 trials), "Low dose fractionated radiation therapy (LDFRT)" (1 trials) and "Optune(NOVOTTF-100A)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ummc Msgcc" are 9 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Ummc Msgcc". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Ummc Msgcc, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Ummc Msgcc, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".

Ummc Msgcc has several departments that took part in Clinical trials: "Rehabilitation R&D Service, Baltimore, MD" - 6 trials, "Kernan Hospital" - 4 trials, "University of Maryland Radiation Oncology Center at Union Hospital" - 2 trials